Evidence map›Paper›PMID 34506517›Full record

ArticlePloS one2021

Designing and validating a Markov model for hospital-based addiction consult service impact on 12-month drug and non-drug related mortality.

Caroline A King, Honora Englander, P Todd Korthuis, Joshua A Barocas, K John McConnell, Cynthia D Morris, Ryan Cook

Open access · goldAbstract readValidation Study
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Caroline A KingDept. of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, OR, United States of America.ORCID 0000-0002-9913-6340
Honora EnglanderDepartment of Medicine, Section of Addiction Medicine, Oregon Health & Science University, Portland, OR, United States of America.ORCID 0000-0003-1863-2041
P Todd KorthuisDepartment of Medicine, Section of Addiction Medicine, Oregon Health & Science University, Portland, OR, United States of America.
Joshua A BarocasSection of Infectious Diseases, Boston University School of Medicine and Boston Medical Center, Boston, MA, United States of America.
K John McConnellCenter for Health Systems Effectiveness, Oregon Health & Science University, Portland, OR, United States of America.
Cynthia D MorrisDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR, United States of America.
Ryan CookDepartment of Medicine, Section of Addiction Medicine, Oregon Health & Science University, Portland, OR, United States of America.
Oregon Health & Science University · USBoston University · US

Funding

Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4M
Western States Node of the National Drug Abuse Treatment Clinical Trials Network (TMS for CUD) UG1DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Keith N. Humphreys, Philip Todd Korthuis · 2015 to 2026
$24.6M
Oregon Clinical and Translational Research Institute TL1 ProgramTL1TR002371 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ALLISON Deborah FRYER, JESSINA C MCGREGOR · 2017 to 2026
$6.2M
NW Center of Excellence & K12 in Patient Centered Learning Health Systems ScienceK12HS026370 · AHRQ · OREGON HEALTH & SCIENCE UNIVERSITY · PI EDEN, KAREN BEEKMAN, GUISE, JEANNE-MARIE · 2018 to 2022
$4.0M
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) StudyUG3DA044831 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KORTHUIS, PHILIP TODD · 2017 to 2018
$895k
Modeling the impact of hospital-based addiction consult services on post-discharge mortalityF30DA052972 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KING, CAROLINE · 2021 to 2021
$36k
AHRQ HHS K12 HS026370NCATS NIH HHS TL1 TR002371NCATS NIH HHS UL1 TR002369NIDA NIH HHS F30 DA052972NIDA NIH HHS UG1 DA015815NIDA NIH HHS UG3 DA044831
6 · The paper itself

Abstract

introductionAddiction consult services (ACS) engage hospitalized patients with opioid use disorder (OUD) in care and help meet their goals for substance use treatment. Little is known about how ACS affect mortality for patients with OUD. The objective of this study was to design and validate a model that estimates the impact of ACS care on 12-month mortality among hospitalized patients with OUD.

methodsWe developed a Markov model of referral to an ACS, post-discharge engagement in SUD care, and 12-month drug-related and non-drug related mortality among hospitalized patients with OUD. We populated our model using Oregon Medicaid data and validated it using international modeling standards.

resultsThere were 6,654 patients with OUD hospitalized from April 2015 through December 2017. There were 114 (1.7%) drug-related deaths and 408 (6.1%) non-drug related deaths at 12 months. Bayesian logistic regression models estimated four percent (4%, 95% CI = 2%, 6%) of patients were referred to an ACS. Of those, 47% (95% CI = 37%, 57%) engaged in post-discharge OUD care, versus 20% not referred to an ACS (95% CI = 16%, 24%). The risk of drug-related death at 12 months among patients in post-discharge OUD care was 3% (95% CI = 0%, 7%) versus 6% not in care (95% CI = 2%, 10%). The risk of non-drug related death was 7% (95% CI = 1%, 13%) among patients in post-discharge OUD treatment, versus 9% not in care (95% CI = 5%, 13%). We validated our model by evaluating its predictive, external, internal, face and cross validity. DISCUSSION: Our novel Markov model reflects trajectories of care and survival for patients hospitalized with OUD. This model can be used to evaluate the impact of other clinical and policy changes to improve patient survival.

Indexed as

Markov ChainsAdultCohort StudiesFemaleHospitalizationHumansMaleMiddle AgedOpioid-Related DisordersOregon

Identifiers

PMID34506517
PMCPMC8432751
OpenAlexW3198027121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.